11-64229288-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_032344.4(NUDT22):​c.621G>C​(p.Leu207Phe) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

NUDT22
NM_032344.4 missense

Scores

10
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.84
Variant links:
Genes affected
NUDT22 (HGNC:28189): (nudix hydrolase 22) Enables UDP-sugar diphosphatase activity and metal ion binding activity. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NUDT22NM_032344.4 linkuse as main transcriptc.621G>C p.Leu207Phe missense_variant 4/6 ENST00000279206.8 NP_115720.2 Q9BRQ3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NUDT22ENST00000279206.8 linkuse as main transcriptc.621G>C p.Leu207Phe missense_variant 4/61 NM_032344.4 ENSP00000279206.3 Q9BRQ3-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 14, 2022The c.621G>C (p.L207F) alteration is located in exon 4 (coding exon 3) of the NUDT22 gene. This alteration results from a G to C substitution at nucleotide position 621, causing the leucine (L) at amino acid position 207 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.50
BayesDel_addAF
Benign
-0.025
T
BayesDel_noAF
Benign
-0.27
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.13
.;T;T
Eigen
Uncertain
0.56
Eigen_PC
Uncertain
0.50
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.82
T;D;D
M_CAP
Benign
0.015
T
MetaRNN
Uncertain
0.52
D;D;D
MetaSVM
Benign
-0.82
T
MutationAssessor
Uncertain
2.5
.;M;.
PrimateAI
Uncertain
0.55
T
PROVEAN
Uncertain
-2.4
N;D;D
REVEL
Benign
0.19
Sift
Uncertain
0.011
D;D;D
Sift4G
Benign
0.067
T;D;T
Polyphen
1.0
.;D;.
Vest4
0.61
MutPred
0.37
.;Loss of methylation at R211 (P = 0.1768);.;
MVP
0.44
MPC
1.3
ClinPred
0.96
D
GERP RS
4.0
Varity_R
0.45
gMVP
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr11-63996760; API